Eledon Total Assets from 2010 to 2024

ELDN Stock  USD 4.85  0.02  0.41%   
Eledon Pharmaceuticals Total Assets yearly trend continues to be very stable with very little volatility. Total Assets are likely to drop to about 81.1 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2013-12-31
Previous Quarter
120.5 M
Current Value
114.6 M
Quarterly Volatility
61.2 M
 
Yuan Drop
 
Covid
Check Eledon Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eledon Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 494.4 K, Interest Expense of 1 M or Selling General Administrative of 10.4 M, as well as many indicators such as Price To Sales Ratio of 149, Dividend Yield of 9.0E-4 or PTB Ratio of 6.5 K. Eledon financial statements analysis is a perfect complement when working with Eledon Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Eledon Pharmaceuticals Correlation against competitors.
To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.

Latest Eledon Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Eledon Pharmaceuticals over the last few years. Total assets refers to the total amount of Eledon Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Eledon Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Eledon Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eledon Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 125.89 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Eledon Total Assets Regression Statistics

Arithmetic Mean66,003,048
Geometric Mean40,888,195
Coefficient Of Variation93.30
Mean Deviation50,832,185
Median32,287,000
Standard Deviation61,583,907
Sample Variance3792.6T
Range186.3M
R-Value0.59
Mean Square Error2673.1T
R-Squared0.35
Significance0.02
Slope8,094,400
Total Sum of Squares53096.1T

Eledon Total Assets History

202481.1 M
2023125.9 M
202292.8 M
2021170.5 M
2020197.2 M
201910.9 M
201817 M

Other Fundumenentals of Eledon Pharmaceuticals

Eledon Pharmaceuticals Total Assets component correlations

0.94-0.76-0.440.66-0.280.92-0.04-0.180.790.28-0.370.510.760.90.9-0.70.6-0.19
0.94-0.75-0.410.68-0.580.89-0.23-0.40.730.17-0.490.470.720.830.82-0.670.51-0.13
-0.76-0.75-0.05-0.470.37-0.860.060.25-0.330.310.060.0-0.71-0.61-0.620.27-0.02-0.31
-0.44-0.41-0.05-0.460.03-0.36-0.18-0.06-0.63-0.710.24-0.790.08-0.36-0.370.62-0.710.68
0.660.68-0.47-0.46-0.330.57-0.15-0.250.660.06-0.310.580.470.680.67-0.620.39-0.06
-0.28-0.580.370.03-0.33-0.330.490.7-0.130.260.420.0-0.26-0.18-0.160.160.02-0.27
0.920.89-0.86-0.360.57-0.330.05-0.070.570.11-0.150.310.620.710.72-0.480.36-0.11
-0.04-0.230.06-0.18-0.150.490.050.79-0.330.170.8-0.19-0.21-0.23-0.20.29-0.030.06
-0.18-0.40.25-0.06-0.250.7-0.070.79-0.310.340.66-0.13-0.41-0.35-0.320.34-0.01-0.21
0.790.73-0.33-0.630.66-0.130.57-0.33-0.310.54-0.710.810.530.880.88-0.930.83-0.55
0.280.170.31-0.710.060.260.110.170.340.54-0.350.67-0.180.220.23-0.50.85-0.8
-0.37-0.490.060.24-0.310.42-0.150.80.66-0.71-0.35-0.58-0.3-0.51-0.490.71-0.610.35
0.510.470.0-0.790.580.00.31-0.19-0.130.810.67-0.580.160.570.54-0.880.84-0.68
0.760.72-0.710.080.47-0.260.62-0.21-0.410.53-0.18-0.30.160.860.83-0.460.210.17
0.90.83-0.61-0.360.68-0.180.71-0.23-0.350.880.22-0.510.570.860.99-0.80.6-0.23
0.90.82-0.62-0.370.67-0.160.72-0.2-0.320.880.23-0.490.540.830.99-0.780.6-0.23
-0.7-0.670.270.62-0.620.16-0.480.290.34-0.93-0.50.71-0.88-0.46-0.8-0.78-0.850.5
0.60.51-0.02-0.710.390.020.36-0.03-0.010.830.85-0.610.840.210.60.6-0.85-0.62
-0.19-0.13-0.310.68-0.06-0.27-0.110.06-0.21-0.55-0.80.35-0.680.17-0.23-0.230.5-0.62
Click cells to compare fundamentals

About Eledon Pharmaceuticals Financial Statements

Eledon Pharmaceuticals investors utilize fundamental indicators, such as Total Assets, to predict how Eledon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Assets125.9 M81.1 M
Intangibles To Total Assets 0.36  0.24 

Pair Trading with Eledon Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eledon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Eledon Stock

  0.69ESPR Esperion TherapeuticsPairCorr

Moving against Eledon Stock

  0.84MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.79LLY Eli LillyPairCorr
  0.77PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.76JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.67VALN Valneva SE ADRPairCorr
The ability to find closely correlated positions to Eledon Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eledon Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eledon Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eledon Pharmaceuticals to buy it.
The correlation of Eledon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eledon Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Eledon Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eledon Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eledon Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eledon Pharmaceuticals Stock:
Check out the analysis of Eledon Pharmaceuticals Correlation against competitors.
To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.73
Return On Assets
(0.33)
Return On Equity
(0.25)
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.